Software Development Manager Joe Sango recently joined the Melbourne Genomics Innovation and Technology team, to further develop the shared system for genomics, GenoVic. To ensure GenoVic delivers benefits to Alliance…
The Alliance’s shared clinical system for genomics, GenoVic, now offers additional tools and has recently completed transition to a new operating entity. Additional capabilities and tools Two accredited testing laboratories…
Dr Edward Chew is a clinician and medical scientist at The Royal Melbourne Hospital. In 2018, Edward was selected to take part in Melbourne Genomics’ Medical Specialists Immersion Program. His project explored how to integrate…
Genomic testing to diagnose children with a suspected complex genetic condition will be funded by Medicare for the first time, benefiting thousands of families across Australia. This new funding is the centrepiece of a raft of…
The team that develops and deploys education activities for Melbourne Genomics continues to deliver its work – online, remotely and in new, creative formats. In the past fortnight, the latest cohort of students commenced the…
A study recently published in Haematologica funded by Melbourne Genomics has found that genomic characterisation – targeted sequencing and whole exome sequencing – resulted in a change of diagnosis for more than a quarter of…
Findings from the Melbourne Genomics Congenital Deafness Clinical Flagship have been published in two notable peer-reviewed journals. One of 16 clinical projects, the Deafness Flagship investigated the impact of genomic testing…
Results from the Melbourne Genomics clinical project investigating the impact of genomic testing for the heart condition dilated cardiomyopathy (DCM) have now been published. DCM is one of 16 areas of health investigated by…
A new podcast now available from ABC Radio National’s Big Ideas program, ‘Is genomic medicine delivering on its potential?’ was recorded at a Melbourne Genomics public forum held late last year. Host Paul Barclay moderates a…
A Melbourne Genomics study published today in Genetics in Medicine has found that more than two-thirds (68 per cent) of parents who consented to genomic testing for hearing loss genes for their infant also accepted the offer of…
Melbourne Genomics acknowledges the Wurundjeri people of the Kulin Nation, on whose lands we work, and all First Nations peoples across Victoria. We pay respect to Elders past and present. We also acknowledge the First Nations health professionals, researchers and leaders who are shaping the future of genomic medicine.